The first public hearing was held on Nov. 19, 2019.
The Department of Consumer and Business Services held its Inaugural Prescription Drug Price Hearing on:
Tuesday, Nov. 19, 5:30 – 7:30 p.m.
Hearing Room 50, Oregon State Capitol
900 Court St. NE, Salem Oregon 97301
The hearing covered several topics, including an overview of the Drug Price Transparency program, results from data collected, and panels on drug pricing. The public had the opportunity to provide comments on prescription drug prices.
View the agenda
Nov. 19 public hearing materials
Presciption Drug Price Transparency Hearing Presentation
Bill Head, Pharmaceutical Care Management Association: OIG Report
Bill Head, Pharmaceutical Care Management Association: GAO Report
Daniel Hartung, Oregon State University and Oregon Health Sciences University: Presentation
Saumil Pandya, Pharmaceutical Research and Manufacturers of America: Presentation
Saumil Pandya, Pharmaceutical Research and Manufacturers of America: Written Testimony
Mihir Patel, PacificSource Health Plans: Written Testimony
The hearing was broadcasted and public comment was accepted by the Division of Financial Regulation staff at the following satellite locations:
- Astoria – Flag Room, Astoria Public Library, 450 10th St., Astoria, OR 97103
- Medford – Room 120, Southern Oregon University - Higher Education Center, 101 S Bartlett St., Medford, OR 97501
- Pendleton – Public Meeting Room, Pendleton Public Library, 502 SW Dorion Ave., Pendleton, OR 97801
The department wants your questions and stories on prescription drug prices. The form below provides you the opportunity to submit your question and story to the department. Staff members will review all questions and stories submitted. All responses submitted are voluntary and you are not required to fill out answers for all the questions below.
Information provided will be analyzed along with data reported by health insurers and prescription drug manufacturers for the annual report to the Oregon State Legislature on prescription drug prices.
Share your Rx drug price story
The survey can be provided upon request in an alternate format for individuals with disabilities or in another language. For questions about accessibility or to request an accommodation, call 503-947-7200 or 833-210-4560 (toll-free), or email email@example.com.
For more information about the Drug Price Transparency Program: